Related references
Note: Only part of the references are listed.Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
Laura C. Coates et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Psoriatic arthritis
Oliver FitzGerald et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Christopher T Ritchlin et al.
LANCET (2020)
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
Dylan McGagh et al.
RHEUMATOLOGY (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
Peter Nash et al.
RHEUMATOLOGY AND THERAPY (2020)
Adult Measures of General Health and Health-Related Quality of Life
Ljoudmila Busija et al.
ARTHRITIS CARE & RESEARCH (2020)
Patient's experience of psoriatic arthritis: a conceptual model based on qualitative interviews
Alexis Ogdie et al.
RMD OPEN (2020)
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study
P. G. Conaghan et al.
RMD OPEN (2020)
ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Quality of life in psoriatic arthritis
Tania Gudu et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Functional impairment measurement in psoriatic arthritis: Importance and challenges
Philip Mease et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
Iain B. McInnes et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice
Richard Holland et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
Ana-Maria Orbai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The psychosocial burden of psoriatic arthritis
M. Elaine Husni et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry
Proton Rahman et al.
BMJ OPEN (2017)
The prevalence of severe fatigue in rheumatic diseases: an international study
Cecile L. Overman et al.
CLINICAL RHEUMATOLOGY (2016)
Patient-Reported Outcomes in Psoriatic Arthritis
Ana-Maria Orbai et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
The experience of pain and redness in patients with moderate to severe plaque psoriasis
Mona L. Martin et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone
Cheryl F. Rosen et al.
RHEUMATOLOGY (2012)
Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction
Philip J. Mease et al.
JOURNAL OF RHEUMATOLOGY (2011)
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study
Alberto Cauli et al.
JOURNAL OF RHEUMATOLOGY (2011)
Occurrence and correlates of fatigue in psoriatic arthritis
J. A. Husted et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people
Fausto Salaffi et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2009)
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
JOURNAL OF PAIN (2008)
A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis
Pinar Borman et al.
CLINICAL RHEUMATOLOGY (2007)
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
D. D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
JT Farrar et al.
PAIN (2001)
Share Paper
